Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis - Wikidata - awgldk - TriplyDB

Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis

Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis

http://www.wikidata.org/entity/Q35789327

about

IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS NF-κB in inflammation and renal diseases The restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in mice Crosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney disease Renoprotective Effect of Lactoferrin against Chromium-Induced Acute Kidney Injury in Rats: Involvement of IL-18 and IGF-1 Inhibition Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis Signaling pathways modulated by fish oil in salt-sensitive hypertension Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans Anti-inflammatory and antiosteoclastogenic activities of parthenolide on human periodontal ligament cells in vitro.n-3 Fatty acids block TNF-α-stimulated MCP-1 expression in rat mesangial cells.Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism.Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy Salvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in rats Antioxidants in kidney diseases: the impact of bardoxolone methyl.Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration The cytokine TWEAK modulates renal tubulointerstitial inflammation.The renal effects of blood glucose-lowering plant-derived extracts in diabetes mellitus--an overview.Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.Salidroside attenuates LPS-stimulated activation of THP-1 cell-derived macrophages through down-regulation of MAPK/NF-kB signaling pathways.Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cells CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB.Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells.Continuous, noninvasive monitoring of local microscopic inflammation using a genetically engineered cell-based biosensor.Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells.The profile of gene expression and role of nuclear factor kappa B on glomerular injury in rats with Thy-1 nephritis.SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases.Protective effects of thymoquinone and methotrexate on the renal injury in collagen-induced arthritis.Endothelial NF-κB Blockade Abrogates ANCA-Induced GN.Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line.Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.Previous Exercise Training Reduces Markers of Renal Oxidative Stress and Inflammation in Streptozotocin-Induced Diabetic Female Rats.

P2860

Q24672467-29B97F7A-E3BE-4F8B-97CD-2B04F496E5D3 Q27021276-AD04FA15-9A3E-4E93-8C03-12B7A033138E Q27318623-CE3B3AB1-D527-41AC-8F7F-896786FA6FC0 Q28080433-EC70E6CC-F80D-49A3-8991-444481047CFE Q28390011-BF707CBE-76CA-42D6-BFED-239A4296064F Q33836248-11C4DDFD-0691-403F-BC69-785AA8B356A5 Q33887250-1ADAA6F7-4F20-41B1-83FB-94BC384775B6 Q34805360-0C339A4A-8164-4773-9D15-BF23B9C66971 Q34909032-B7E03EBB-69E0-424B-96D2-DB2EBA27A161 Q34979637-FFC766E7-F774-439D-B59F-300A4EC63176 Q35022648-0993E84B-1367-4242-AFDF-21AFE8DC8D4F Q35151900-984F6B15-4AAC-4ADF-9844-E19DA2012E2A Q35869192-4BEE5E93-2E14-4356-8F00-35E5525F397E Q36026304-89754135-E0CC-486F-A5AF-C0130D971D01 Q36168835-7563A6AA-D710-4E0C-B11E-4076743B2FF7 Q36482195-75E57FEB-4BE7-496B-B03C-EE77742314C5 Q36666882-55105CE8-26C2-44C1-A2DE-6EBCA37CB01E Q37683784-59859208-F85B-48F3-AA0C-62DFFF7F7516 Q38894222-FA039CD8-FEA7-4CC1-815E-BC18DC6174E0 Q39117266-8325FAC6-7B73-40AA-B9C0-EC23E648AA10 Q39456654-A0674D34-CB13-4BB4-9CB0-612E6004D0EF Q39855226-B721F175-2E9B-4EF9-A3ED-2CFD69785E63 Q40175734-25F5933F-3891-41FE-9F43-21F4D9BA8C59 Q40370035-2ADC90B4-0FC1-43E2-B9A0-0A15A990E8D3 Q40380519-140132F1-CCB9-46E3-B1ED-E8193AC0E3B2 Q41480524-E7ADA827-FC84-4A17-890C-66BDE3E3F7E9 Q46636442-F0915E9F-7F98-4695-B380-C7D5CAA9CCA3 Q46797106-1DDB4E1E-2D26-4117-B289-7BE7FA6A70FA Q47756541-7616B7E4-5E8E-474B-8E4B-CBEEE3AA7E0A Q48708589-D94BB2A4-AD1B-4027-BB1D-FA887E4D7AD8 Q50902532-EA901B15-0D72-412B-85B1-8018489D4999 Q52690261-76642129-FF91-4A0F-8FA8-AE4372FD07B7 Q55058976-0AB1B6E8-8FE5-4161-871E-2A60EEC09B65 Q55213982-8B4CB12D-6933-41C6-B04D-8BDB8F4B2DB3

P2860

Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis

http://www.wikidata.org/entity/Q35789327

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Nuclear factor-kappa B inhibit ...... t of immune glomerulonephritis

@ast

Nuclear factor-kappa B inhibit ...... t of immune glomerulonephritis

@en

type

label

Nuclear factor-kappa B inhibit ...... t of immune glomerulonephritis

@ast

Nuclear factor-kappa B inhibit ...... t of immune glomerulonephritis

@en

prefLabel

Nuclear factor-kappa B inhibit ...... t of immune glomerulonephritis

@ast

Nuclear factor-kappa B inhibit ...... t of immune glomerulonephritis

@en

P1433

Q35789327-E1504005-BEC8-4B6F-8EA8-C07F5AA58DC0

P1476

Q35789327-4272CE15-2396-4E15-B74A-9815BC0AEB27

P2093

Q35789327-041FA0CE-A955-44B4-81B3-495CABB6DB6F

Q35789327-0BD9B83D-992F-401A-A6E1-AFE1D1228E6C

Q35789327-163A7AD1-2A9A-4658-B6D5-EDC427BCF1A1

Q35789327-429869F5-DCFC-4E2C-BEE9-028BE700A011

Q35789327-713A2451-71A1-4BBA-888E-0AB3CAD0AFB0

Q35789327-815D604F-C852-4405-A5B7-ED1DA9DB446E

Q35789327-82EAD44D-0A02-4246-99DF-71CD7A0F8BD1

Q35789327-8716EB01-2216-45CF-9BC0-A08A4B8F11FE

Q35789327-F6E236F4-3044-484F-93EC-D36369E01E2B

P2860

Q35789327-0EB36CC5-DFE8-476C-A559-4C4F75080CC0

Q35789327-0ECDB6EB-7C25-46A6-B722-652BEC02E807

Q35789327-133974B1-313E-428F-93C4-00B59A0101D5

Q35789327-14D41B43-35C4-4B43-AD0F-C2F1ED15F654

Q35789327-1D1D8324-BB64-442D-9C7E-5D32CA06B98E

Q35789327-251ADDE4-DAE0-49F6-A497-52D5596F7714

Q35789327-2B6DAAE3-9A65-4BEF-B342-567E081C68E5

Q35789327-2C7ADB80-7D2E-4760-9211-079280390CE2

Q35789327-2DDCFC17-955B-4C37-94AE-458F27229D9A

Q35789327-344FF211-40A2-4FA3-9F6D-D09F3D3CBFF5

P304

Q35789327-8896D538-061B-4519-ACFE-5DD8C4488AC1

P31

Q35789327-F57BE9EA-D253-4257-B74E-B901C2BD3AB1

P356

Q35789327-B52BF0BC-D4F6-4446-A4EF-B9DBCA697BBF

P407

Q35789327-E241038F-A1C4-40CE-82AC-62729A97DE90

P433

Q35789327-A792AB0C-A411-43C6-B6DE-922FA99F783D

P478

Q35789327-3C65EEDE-788B-40DC-AAC3-881844061ECF

P577

Q35789327-5E30DC04-95F9-4F4E-B177-BB4B7033F082

P698

Q35789327-E97B0FE7-29B0-4439-AA32-62BD650E48E6

P921

Q35789327-18275B33-7B95-48E3-A082-C055D9F36B74

Q35789327-5C606ADE-4220-4413-95C4-8C794011BC22

P932

Q35789327-92D06F0D-C0A5-4329-B55B-F5A28A8592B8

P356

S0002-9440(10)64425-2

P1433

The American Journal of Pathology

P1476

Nuclear factor-kappa B inhibit ...... t of immune glomerulonephritis

@en

P2093

Carmen Gómez-Guerrero

http://www.w3.org/2001/XMLSchema#string

Guillermo Sanjuán

http://www.w3.org/2001/XMLSchema#string

Jeffrey Kopp

http://www.w3.org/2001/XMLSchema#string

Jesús Egido

http://www.w3.org/2001/XMLSchema#string

Julia Blanco

http://www.w3.org/2001/XMLSchema#string

Oscar López-Franco

http://www.w3.org/2001/XMLSchema#string

Purificación Hernández-Vargas

http://www.w3.org/2001/XMLSchema#string

Yoshikage Yo

http://www.w3.org/2001/XMLSchema#string

Yusuke Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

New insights into the role of nuclear factor-KB, a ubiquitous transcription factor in the initiation of diseases

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

NF-kappaB: a key role in inflammatory diseases

Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells.

Transcription factor-kappa B (NF-kappa B) and renal disease.

Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species.

The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.

Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones.

In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi.

P304

1497-1505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)64425-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12368222

http://www.w3.org/2001/XMLSchema#string

P921

glomerulonephritis

P932

1867308

http://www.w3.org/2001/XMLSchema#string